Center for Alzheimer's and Neurodegenerative Diseases

Fingerprint Dive into the research topics where Center for Alzheimer's and Neurodegenerative Diseases is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

  • Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Research Output

    Target engagement in an alzheimer trial: Crenezumab lowers amyloid β oligomers in cerebrospinal fluid

    Yang, T., Dang, Y., Ostaszewski, B., Mengel, D., Steffen, V., Rabe, C., Bittner, T., Walsh, D. M. & Selkoe, D. J., Aug 2019, In : Annals of Neurology. 86, 2, p. 215-224 10 p.

    Research output: Contribution to journalArticle

    Open Access
  • 7 Scopus citations

    A highly sensitive novel immunoassay specifically detects low levels of soluble Aβ oligomers in human cerebrospinal fluid

    Yang, T., O'Malley, T. T., Kanmert, D., Jerecic, J., Zieske, L. R., Zetterberg, H., Hyman, B. T., Walsh, D. M. & Selkoe, D. J., 2015, In : Alzheimer's Research and Therapy. 7, 1, 7.

    Research output: Contribution to journalArticle

    Open Access
  • 45 Scopus citations

    Soluble Aβ oligomers are rapidly sequestered from brain ISF in vivo and bind GM1 ganglioside on cellular membranes

    Hong, S., Ostaszewski, B. L., Yang, T., O'Malley, T. T., Jin, M., Yanagisawa, K., Li, S., Bartels, T. & Selkoe, D. J., Apr 16 2014, In : Neuron. 82, 2, p. 308-319 12 p.

    Research output: Contribution to journalArticle

    Open Access
  • 98 Scopus citations